Aristo Bio-Tech and Lifescience Ltd

Aristo Bio-Tech and Lifescience Other Announcement

Aristo Bio-Tech sent a Reg 36(1)(b) web-link letter for its FY 2025-26 Annual Report to shareholders without email IDs. No financial or business event is disclosed.

Aristo Bio-Tech and Lifescience Annual General Meeting

Aristo Bio-Tech and Lifescience Limited has issued a notice for its 21st Annual General Meeting to be held on September 30, 2026.

Aristo Bio-Tech and Lifescience Board Meeting Outcome

Aristo Bio-Tech declared a final dividend of Rs. 0.60 per share and approved re-appointments for directors and the cost auditor.

Aristo Bio-Tech and Lifescience H2 FY26 Results: Turns Profitable, Net Profit ₹3 Cr

Aristo Bio-Tech and Lifescience Ltd reported revenue from operations of ₹107.3 Cr (+3.3% YoY) and net profit of ₹3 Cr for H2 FY26.

Key figure

Net profit ₹3 Cr

Aristo Bio-Tech and Lifescience Financial Results

Aristo Bio-Tech approved audited FY26 financial results and recommended a final dividend of ₹0.60 per share. The results showed strong annual performance with unmodified audit opinions.

Aristo Bio-Tech and Lifescience Other Announcement

Aristo Bio-Tech submitted its annual SDD compliance certificate for FY 2025-26. The certificate confirms maintenance of the mandatory structured digital database for insider trading monitoring.

Aristo Bio-Tech and Lifescience Board Meeting Date

Aristo Bio-Tech scheduled a board meeting for May 29, 2026, to consider audited FY26 results and a final dividend. Trading remains closed until May 31.